Gary Wilson
Psychiatry · Tyler, TXNPI 1639249014
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 193 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations.
Across 193 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$641
- Sunovion Pharmaceuticals Inc.$434
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$349
- Ironshore Pharmaceuticals Inc.$346
- Otsuka America Pharmaceutical, Inc.$314
- Supernus Pharmaceuticals, Inc.$250
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,708100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $641 |
| Sunovion Pharmaceuticals Inc. | 40 | $434 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $349 |
| Ironshore Pharmaceuticals Inc. | 8 | $346 |
| Otsuka America Pharmaceutical, Inc. | 17 | $314 |
| Supernus Pharmaceuticals, Inc. | 13 | $250 |
| Johnson & Johnson | 11 | $233 |
| Neurocrine Biosciences, Inc. | 12 | $225 |
| Indivior Inc. | 10 | $202 |
| Teva Pharmaceuticals USA, Inc. | 9 | $153 |
| E.r. Squibb & Sons, L.L.C. | 1 | $111 |
| Almatica Pharma LLC | 5 | $92 |
| Vanda Pharmaceuticals Inc. | 5 | $83 |
| Lundbeck LLC | 4 | $70 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $56 |
| Alkermes, Inc. | 3 | $50 |
| Corium, LLC | 3 | $42 |
| Shire North American Group Inc | 2 | $26 |
| Adlon Therapeutics L.p. | 1 | $22 |
| Eisai Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$250
- VRAYLAR$226
- QELBREE$125
- ELIQUIS$111
- CAPLYTA$100
How this compares
$3,718 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Tyler
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
- Frank ChenHouston$941K
- Alice MaoHouston$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.